Oppenheimer Reiterates Outperform on UnitedHealth Group, Maintains $610 Price Target
Portfolio Pulse from richadhand@benzinga.com
Oppenheimer analyst Michael Wiederhorn has reiterated an Outperform rating on UnitedHealth Group (NYSE:UNH) and maintained a $610 price target.
July 17, 2023 | 1:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
UnitedHealth Group's stock rating has been reiterated as Outperform by Oppenheimer, with a maintained price target of $610.
The reiteration of an Outperform rating by Oppenheimer indicates a positive outlook for UnitedHealth Group. The maintained price target of $610 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100